What are the major opportunities in the Isovaleric Acidemia IVA Treatment market? What are the strategies for the Isovaleric Acidemia IVA Treatment market?

For detailed insights on the major opportunities and strategies in the Isovaleric Acidemia IVA Treatment market, Read More

How does the Isovaleric Acidemia IVA Treatment market relate to the overall economy and other similar markets?

For detailed insights on Isovaleric Acidemia IVA Treatment's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Isovaleric Acidemia IVA Treatment market growth? SWOT analysis of the Isovaleric Acidemia IVA Treatment market.

For detailed insights on the key dynamics influencing the Isovaleric Acidemia IVA Treatment market growth and SWOT analysis of the Isovaleric Acidemia IVA Treatment industry, Read More

Global Isovaleric Acidemia (IVA) Treatment Market Report 2025

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Isovaleric Acidemia (IVA) Treatment Global Market Report 2025

Name: Isovaleric Acidemia (IVA) Treatment Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Classical Isovaleric Acidemia, Moderate Isovaleric Acidemia, Non-classical Isovaleric Acidemia), By Treatment (Dietary Management, Enzyme Replacement Therapy, Gene Therapy, Pharmacological Treatment), By Route of Administration (Oral, Injectable,By End-user (Hospitals, Clinics, Homecare Settings) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Isovaleric Acidemia (IVA) Treatment Market Overview

• Isovaleric Acidemia (IVA) Treatment market size has reached to $0.6 billion in 2024

• Expected to grow to $0.79 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%

• Growth Driver: Rising Prevalence Of Metabolic Disorders Fueling The Growth Of The Market Due To Increasing Demand For Metabolic Disease Management

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Isovaleric Acidemia (IVA) Treatment Market?

Isovaleric acidemia (IVA) treatment refers to the medical management of a rare inherited metabolic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase, leading to a buildup of isovaleric acid in the body. Treatment focuses on reducing the accumulation of toxic substances and preventing metabolic crises.

The main types of isovaleric acidemia (IVA) treatment include classical isovaleric acidemia, moderate isovaleric acidemia, and non-classical isovaleric acidemia. Classical isovaleric acidemia is a severe, inherited metabolic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase, which is essential for breaking down the amino acid leucine. Treatments involved for isovaleric acidemia (IVA) treatment are dietary management, enzyme replacement therapy, gene therapy, and pharmacological treatment. The various routes of administration include oral and injectable and are used by several end-users, such as hospitals, clinics, and homecare settings.

Isovaleric Acidemia (IVA) Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Isovaleric Acidemia (IVA) Treatment Market Size 2025 And Growth Rate?

What Is The Isovaleric Acidemia (IVA) Treatment Market Growth Forecast?

The isovaleric acidemia (IVA) treatment market size is expected to see strong growth in the next few years. It will grow to $0.79 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing adoption of gene therapy approaches, rising investment in rare disease research, a growing pipeline of novel treatment options, increasing collaborations between biotech firms and research institutes, and a rising focus on personalized medicine for metabolic disorders. Major trends in the forecast period include advancements in genetic testing technologies, advanced drug delivery systems for metabolic therapies, innovation in enzyme replacement formulations, the development of targeted gene editing tools, and advancements in newborn screening methodologies.

The forecast of 5.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of import duties could hinder metabolic genetics centers by increasing prices of isovaleric acidemia-specific amino acid formulas sourced from Italy and the Netherlands, potentially reducing rare disease management options and raising inherited metabolic disorder care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Isovaleric Acidemia (IVA) Treatment Market Segmented?

1) By Type: Classical Isovaleric Acidemia, Moderate Isovaleric Acidemia, Non-classical Isovaleric Acidemia

2) By Treatment: Dietary Management, Enzyme Replacement Therapy, Gene Therapy, Pharmacological Treatment

3) By Route of Administration: Oral, Injectable

4)By End-user: Hospitals, Clinics, Homecare Settings

Subsegments:

1) By Classical Isovaleric Acidemia: Dietary Management, Carnitine Supplementation, Glycine Supplementation, Emergency Management, Gene Therapy (Investigational)

2) By Non-classical Isovaleric Acidemia: Observation and Preventive Care, Mild Dietary Modifications, Occasional Supplementation, Genetic Counseling and Monitoring

3) By Moderate Isovaleric Acidemia: Protein-restricted Diet, Intermittent Carnitine/Glycine Therapy, Periodic Monitoring and Supportive Care, Acute Episode Management

What Is Driving The Isovaleric Acidemia (IVA) Treatment Market? Rising Prevalence Of Metabolic Disorders Fueling The Growth Of The Market Due To Increasing Demand For Metabolic Disease Management

The increasing prevalence of metabolic disorders is expected to propel the growth of the isovaleric acidemia (IVA) treatment market going forward. Metabolic disorders are conditions that disrupt normal metabolic processes, affecting how the body converts food into energy. Common types of metabolic disorders include diabetes mellitus, hypothyroidism, hyperthyroidism, phenylketonuria (PKU), galactosemia, maple syrup urine disease (MSUD), isovaleric acidemia (IVA), Gaucher disease, Fabry disease, Wilson’s disease, and various lysosomal storage disorders. The prevalence of metabolic disorders is due to lifestyle-related factors such as poor diet and physical inactivity, which contribute to conditions like obesity and insulin resistance. Isovaleric acidemia treatment helps manage metabolic disorders by addressing the buildup of toxic substances in the body, restoring normal metabolic function, and preventing complications like neurological damage. For instance, in November 2023, according to the American Diabetes Association, a US-based non-profit organization, in 2022, around 25.5 million people in the U.S. were diagnosed with diabetes, accounting for 7.6% of the total population. Therefore, the increasing prevalence of metabolic disorders drives the growth of the isovaleric acidemia (IVA) treatment industry.

What Is Driving The Isovaleric Acidemia (IVA) Treatment Market? Growing Awareness Of Rare Genetic Disorders Driving The Growth Of The Market Due To Improved Diagnosis And Early Detection

The increasing awareness of rare genetic disorders is expected to propel the growth of the isovaleric acidemia (IVA) treatment market going forward. Rare genetic disorders refer to conditions caused by gene mutations that are infrequent in the population, often affecting a small number of individuals. Rare genetic disorders are increasing due to improved diagnostic technologies and expanded genetic screening programs, which enable earlier and more accurate detection. Isovaleric acidemia treatment helps manage this rare genetic disorder by providing a specialized dietary regimen, supplementation with amino acids, and sometimes medications, which reduce the buildup of toxic metabolites and prevent metabolic crises, improving the quality of life for affected individuals. For instance, in February 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, each year, birth abnormalities cause 240,000 newborn deaths within the first 28 days and an additional 170,000 deaths in children aged 1 month to 5 years, including conditions like heart defects, neural tube defects, and Down syndrome. Moreover, in February 2023, according to the Rady Children's Institute for Genomic Medicine, a US-based research institute, in a study conducted at Rady Children's Hospital, 41% of infant deaths were attributed to single-locus (Mendelian) genetic diseases. Therefore, the increasing prevalence of metabolic disorders drives the growth of the isovaleric acidemia (IVA) treatment industry.

What Is Driving The Isovaleric Acidemia (IVA) Treatment Market? Rising Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genetic Testing And Tailored Therapies

Growing focus on personalized medicine is expected to propel the growth of the isovaleric acidemia (IVA) treatment market going forward. Personalized medicine, also known as precision medicine, is an innovative approach to healthcare that tailors medical treatment to individual characteristics, such as genetics, lifestyle, and environment. Personalized medicine is increasing due to genetic testing and biomarker research advancements, enabling more precise and tailored treatments for individual patients. Isovaleric acidemia (IVA) treatment exemplifies personalized medicine by utilizing genetic insights to customize dietary and pharmacological interventions based on individual metabolic profiles, improving outcomes and minimizing complications. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based organization promoting the adoption of personalized medicine, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from 6 in 2022. Therefore, the growing focus on personalized healthcare is driving the growth of the isovaleric acidemia (IVF) treatment market.

Who Are The Major Players In The Global Isovaleric Acidemia (IVA) Treatment Market?

Major companies operating in the isovaleric acidemia (IVA) treatment market are Nestlé Health Science S.A., BioMarin Pharmaceutical Inc., GenScript Biotech Corporation, Nutricia Advanced Medical Nutrition, Rocket Pharmaceuticals Inc., REGENXBIO Inc., uniQure N.V., Vitaflo International Ltd., Orchard Therapeutics plc, Editas Medicine Inc., Cambrooke Therapeutics Inc., Recordati Rare Diseases Inc., Abbott Nutrition, Targeted Medical Pharma Inc., Solace Nutrition LLC, Nutricia Metabolics, Bluebird Bio Inc., Verve Therapeutics Inc., Abeona Therapeutics Inc., CRISPR Therapeutics AG

Need data on a specific region in this market?

Request Regional Data

What Is The Regional Outlook For The Global Isovaleric Acidemia (IVA) Treatment Market?

North America was the largest region in the isovaleric acidemia (IVA) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Isovaleric Acidemia (IVA) Treatment Market?

The isovaleric acidemia (IVA) treatment market consists of revenues earned by entities by providing services such as newborn screening programs, monitoring, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The isovaleric acidemia (IVA) treatment market includes sales of anticatabolic agents, L-carnitine supplements, and amino acid supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Isovaleric Acidemia (IVA) Treatment Industry?

The isovaleric acidemia (iva) treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the isovaleric acidemia (iva) treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Isovaleric Acidemia IVA Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$0.63 billion
Revenue Forecast In 2034	$0.79 billion
Growth Rate	CAGR of 5.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The isovaleric acidemia (IVA) treatment market covered in this report is segmented – 1) By Type: Classical Isovaleric Acidemia, Moderate Isovaleric Acidemia, Non-classical Isovaleric Acidemia 2) By Treatment: Dietary Management, Enzyme Replacement Therapy, Gene Therapy, Pharmacological Treatment 3) By Route of Administration: Oral, Injectable 4)By End-user: Hospitals, Clinics, Homecare Settings Subsegments: 1) By Classical Isovaleric Acidemia: Dietary Management, Carnitine Supplementation, Glycine Supplementation, Emergency Management, Gene Therapy (Investigational) 2) By Non-classical Isovaleric Acidemia: Observation and Preventive Care, Mild Dietary Modifications, Occasional Supplementation, Genetic Counseling and Monitoring 3) By Moderate Isovaleric Acidemia: Protein-restricted Diet, Intermittent Carnitine/Glycine Therapy, Periodic Monitoring and Supportive Care, Acute Episode Management
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Nestlé Health Science S.A., BioMarin Pharmaceutical Inc., GenScript Biotech Corporation, Nutricia Advanced Medical Nutrition, Rocket Pharmaceuticals Inc., REGENXBIO Inc., uniQure N.V., Vitaflo International Ltd., Orchard Therapeutics plc, Editas Medicine Inc., Cambrooke Therapeutics Inc., Recordati Rare Diseases Inc., Abbott Nutrition, Targeted Medical Pharma Inc., Solace Nutrition LLC, Nutricia Metabolics, Bluebird Bio Inc., Verve Therapeutics Inc., Abeona Therapeutics Inc., CRISPR Therapeutics AG
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Isovaleric Acidemia (IVA) Treatment Market Characteristics

3. Isovaleric Acidemia (IVA) Treatment Market Trends And Strategies

4. Isovaleric Acidemia (IVA) Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Isovaleric Acidemia (IVA) Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Isovaleric Acidemia (IVA) Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Isovaleric Acidemia (IVA) Treatment Market Growth Rate Analysis

5.4. Global Isovaleric Acidemia (IVA) Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Isovaleric Acidemia (IVA) Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Isovaleric Acidemia (IVA) Treatment Total Addressable Market (TAM)

6. Isovaleric Acidemia (IVA) Treatment Market Segmentation

6.1. Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Classical Isovaleric Acidemia

Moderate Isovaleric Acidemia

Non-classical Isovaleric Acidemia

6.2. Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dietary Management

Enzyme Replacement Therapy

Gene Therapy

Pharmacological Treatment

6.3. Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Injectable

6.4. Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Homecare Settings

6.5. Global Isovaleric Acidemia (IVA) Treatment Market, Sub-Segmentation Of Classical Isovaleric Acidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dietary Management

Carnitine Supplementation

Glycine Supplementation

Emergency Management

Gene Therapy (Investigational)

6.6. Global Isovaleric Acidemia (IVA) Treatment Market, Sub-Segmentation Of Non-classical Isovaleric Acidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Observation and Preventive Care

Mild Dietary Modifications

Occasional Supplementation

Genetic Counseling and Monitoring

6.7. Global Isovaleric Acidemia (IVA) Treatment Market, Sub-Segmentation Of Moderate Isovaleric Acidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein-restricted Diet

Intermittent Carnitine/Glycine Therapy

Periodic Monitoring and Supportive Care

Acute Episode Management

7. Isovaleric Acidemia (IVA) Treatment Market Regional And Country Analysis

7.1. Global Isovaleric Acidemia (IVA) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Isovaleric Acidemia (IVA) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Isovaleric Acidemia (IVA) Treatment Market

8.1. Asia-Pacific Isovaleric Acidemia (IVA) Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Isovaleric Acidemia (IVA) Treatment Market

9.1. China Isovaleric Acidemia (IVA) Treatment Market Overview

9.2. China Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Isovaleric Acidemia (IVA) Treatment Market

10.1. India Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Isovaleric Acidemia (IVA) Treatment Market

11.1. Japan Isovaleric Acidemia (IVA) Treatment Market Overview

11.2. Japan Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Isovaleric Acidemia (IVA) Treatment Market

12.1. Australia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Isovaleric Acidemia (IVA) Treatment Market

13.1. Indonesia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Isovaleric Acidemia (IVA) Treatment Market

14.1. South Korea Isovaleric Acidemia (IVA) Treatment Market Overview

14.2. South Korea Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Isovaleric Acidemia (IVA) Treatment Market

15.1. Western Europe Isovaleric Acidemia (IVA) Treatment Market Overview

15.2. Western Europe Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Isovaleric Acidemia (IVA) Treatment Market

16.1. UK Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Isovaleric Acidemia (IVA) Treatment Market

17.1. Germany Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Isovaleric Acidemia (IVA) Treatment Market

18.1. France Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Isovaleric Acidemia (IVA) Treatment Market

19.1. Italy Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Isovaleric Acidemia (IVA) Treatment Market

20.1. Spain Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Isovaleric Acidemia (IVA) Treatment Market

21.1. Eastern Europe Isovaleric Acidemia (IVA) Treatment Market Overview

21.2. Eastern Europe Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Isovaleric Acidemia (IVA) Treatment Market

22.1. Russia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Isovaleric Acidemia (IVA) Treatment Market

23.1. North America Isovaleric Acidemia (IVA) Treatment Market Overview

23.2. North America Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Isovaleric Acidemia (IVA) Treatment Market

24.1. USA Isovaleric Acidemia (IVA) Treatment Market Overview

24.2. USA Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Isovaleric Acidemia (IVA) Treatment Market

25.1. Canada Isovaleric Acidemia (IVA) Treatment Market Overview

25.2. Canada Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Isovaleric Acidemia (IVA) Treatment Market

26.1. South America Isovaleric Acidemia (IVA) Treatment Market Overview

26.2. South America Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Isovaleric Acidemia (IVA) Treatment Market

27.1. Brazil Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Isovaleric Acidemia (IVA) Treatment Market

28.1. Middle East Isovaleric Acidemia (IVA) Treatment Market Overview

28.2. Middle East Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Isovaleric Acidemia (IVA) Treatment Market

29.1. Africa Isovaleric Acidemia (IVA) Treatment Market Overview

29.2. Africa Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Isovaleric Acidemia (IVA) Treatment Market Competitive Landscape And Company Profiles

30.1. Isovaleric Acidemia (IVA) Treatment Market Competitive Landscape

30.2. Isovaleric Acidemia (IVA) Treatment Market Company Profiles

30.2.1. Nestlé Health Science S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. BioMarin Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Nutricia Advanced Medical Nutrition Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Rocket Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Isovaleric Acidemia (IVA) Treatment Market Other Major And Innovative Companies

31.1. REGENXBIO Inc.

31.2. uniQure N.V.

31.3. Vitaflo International Ltd.

31.4. Orchard Therapeutics plc

31.5. Editas Medicine Inc.

31.6. Cambrooke Therapeutics Inc.

31.7. Recordati Rare Diseases Inc.

31.8. Abbott Nutrition

31.9. Targeted Medical Pharma Inc.

31.10. Solace Nutrition LLC

31.11. Nutricia Metabolics

31.12. Bluebird Bio Inc.

31.13. Verve Therapeutics Inc.

31.14. Abeona Therapeutics Inc.

31.15. CRISPR Therapeutics AG

32. Global Isovaleric Acidemia (IVA) Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Isovaleric Acidemia (IVA) Treatment Market

34. Recent Developments In The Isovaleric Acidemia (IVA) Treatment Market

35. Isovaleric Acidemia (IVA) Treatment Market High Potential Countries, Segments and Strategies

35.1 Isovaleric Acidemia (IVA) Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Isovaleric Acidemia (IVA) Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Isovaleric Acidemia (IVA) Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Isovaleric Acidemia (IVA) Treatment Market, Sub-Segmentation Of Classical Isovaleric Acidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Isovaleric Acidemia (IVA) Treatment Market, Sub-Segmentation Of Non-classical Isovaleric Acidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Isovaleric Acidemia (IVA) Treatment Market, Sub-Segmentation Of Moderate Isovaleric Acidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Isovaleric Acidemia (IVA) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Isovaleric Acidemia (IVA) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Nestlé Health Science S.A. Financial Performance

Table 79: BioMarin Pharmaceutical Inc. Financial Performance

Table 80: GenScript Biotech Corporation Financial Performance

Table 81: Nutricia Advanced Medical Nutrition Financial Performance

Table 82: Rocket Pharmaceuticals Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Isovaleric Acidemia (IVA) Treatment Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Isovaleric Acidemia (IVA) Treatment Market, Sub-Segmentation Of Classical Isovaleric Acidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Isovaleric Acidemia (IVA) Treatment Market, Sub-Segmentation Of Non-classical Isovaleric Acidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Isovaleric Acidemia (IVA) Treatment Market, Sub-Segmentation Of Moderate Isovaleric Acidemia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Isovaleric Acidemia (IVA) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Isovaleric Acidemia (IVA) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Isovaleric Acidemia (IVA) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Nestlé Health Science S.A. Financial Performance

Figure 79: BioMarin Pharmaceutical Inc. Financial Performance

Figure 80: GenScript Biotech Corporation Financial Performance

Figure 81: Nutricia Advanced Medical Nutrition Financial Performance

Figure 82: Rocket Pharmaceuticals Inc. Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Pharmaceutical Isolator Global Market Report 2025 – By Type (Closed Isolator Systems, Open Isolator Systems), By Configuration (Floor-Standing, Modular, Mobile, Compact, Tabletop, Portable), By Application (Aseptic Isola...

Thalassemia Drugs Global Market Report 2025 – By Type (Alpha Thalassemia Drugs, Beta Thalassemia Drugs), By Treatment Type (Iron Chelation Therapy, Other Treatments), By Distribution Channel (Hospital Pharmacies, Online ...

Chemotherapy-Induced Anemia Global Market Report 2025 – By Anemia (Mild Anemia, Moderate Anemia, Severe Anemia, Life-Threatening Anemia), By Treatment Type (RBC (Red Blood Cells) Transfusion, Erythropoiesis-Stimulating A...

Iron Deficiency Injectable Global Market Report 2025 – By Type (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose), By Branded or Generics (Branded, Generics), By Application (Chronic Kidney Disease, Inflammatory Bowel D...

Convalescent Plasma Therapy Global Market Report 2025 – By Antibody type (IgM, IgG, IgA), By Application (Prophylaxis, Treatment), By End-Users (Hospitals & Clinics, Laboratories & Research institutes) – Impact of Tariff...

Stearic Acid Global Market Report 2025 – By Feedstock (Animal-Based Raw Materials, Vegetable-Based Raw Materials), By Sales Channel (Direct Sales, Indirect Sales), By End-Use Industry (Agriculture, Automotive, Textiles, ...

Aplastic Anemia Global Market Report 2025 – By Disease Type (Acquired Aplastic Anemia, Inherited Bone Marrow Failure Syndromes), By Treatment Type (Bone Marrow Transfusion Or Stem Cell Therapy, Blood Transfusion, Drug Th...

Frequently Asked Questions

What is the definition of the Isovaleric Acidemia (IVA) Treatment market?

How will the Isovaleric Acidemia (IVA) Treatment market drivers and restraints affect the market dynamics? What forces will shape the Isovaleric Acidemia (IVA) Treatment industry going forward?

The market major growth driver - Rising Prevalence Of Metabolic Disorders Fueling The Growth Of The Market Due To Increasing Demand For Metabolic Disease Management. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Isovaleric Acidemia (IVA) Treatment market?

The isovaleric acidemia (IVA) treatment market size has grown strongly in recent years. It will grow from $0.6 billion in 2024 to $0.63 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increasing awareness of rare metabolic disorders, a rising number of newborn screening programs, a rise in government funding for orphan diseases, increasing focus on enzyme replacement therapies, and rising demand for early diagnosis and genetic counseling. The isovaleric acidemia (IVA) treatment market size is expected to see strong growth in the next few years. It will grow to " $0.79 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing adoption of gene therapy approaches, rising investment in rare disease research, a growing pipeline of novel treatment options, increasing collaborations between biotech firms and research institutes, and a rising focus on personalized medicine for metabolic disorders. Major trends in the forecast period include advancements in genetic testing technologies, advanced drug delivery systems for metabolic therapies, innovation in enzyme replacement formulations, the development of targeted gene editing tools, and advancements in newborn screening methodologies. For further insights on this market, request a sample here

How is the Isovaleric Acidemia (IVA) Treatment market segmented?

The isovaleric acidemia (iva) treatment market covered in this report is segmented –
1) By Type: Classical Isovaleric Acidemia, Moderate Isovaleric Acidemia, Non-classical Isovaleric Acidemia
2) By Treatment: Dietary Management, Enzyme Replacement Therapy, Gene Therapy, Pharmacological Treatment
3) By Route of Administration: Oral, Injectable
4)By End-user: Hospitals, Clinics, Homecare Settings Subsegments:
1) By Classical Isovaleric Acidemia: Dietary Management, Carnitine Supplementation, Glycine Supplementation, Emergency Management, Gene Therapy (Investigational)
2) By Non-classical Isovaleric Acidemia: Observation and Preventive Care, Mild Dietary Modifications, Occasional Supplementation, Genetic Counseling and Monitoring
3) By Moderate Isovaleric Acidemia: Protein-restricted Diet, Intermittent Carnitine/Glycine Therapy, Periodic Monitoring and Supportive Care, Acute Episode Management For further insights on this market, request a sample here

Which region has the largest share of the Isovaleric Acidemia (IVA) Treatment market? What are the other regions covered in the report?

North America was the largest region in the isovaleric acidemia (IVA) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the isovaleric acidemia (IVA) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Isovaleric Acidemia (IVA) Treatment market?

What are the key trends in the Isovaleric Acidemia (IVA) Treatment market?

For further insights on this market, request a sample here.